Skip to main content
logo
Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
78.00
-2.20 (-2.74%)
Mar 4, 2026, 10:49 AM CST

Steminent Biotherapeutics Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-158.75-129.23-85.47-124.2-55.21
Depreciation & Amortization
16.4312.069.4311.3315.38
Loss (Gain) From Sale of Assets
----00.01
Loss (Gain) From Sale of Investments
---0.46-
Stock-Based Compensation
15.888.582.720.630.54
Other Operating Activities
0.05-0.64-0.1953.3210.33
Change in Accounts Receivable
-0.10.65-0.550.34
Change in Inventory
-4.33-4.196.930.22.33
Change in Accounts Payable
0.390.231.28-0.21-3.3
Change in Unearned Revenue
--0.46-0.641.020.08
Change in Other Net Operating Assets
-9.1-1.25-3.92.9-1.96
Operating Cash Flow
-139.41-114.81-69.2-55.11-31.47
Capital Expenditures
-87.15-27.46-2.32-0.6-
Sale of Property, Plant & Equipment
---0-
Sale (Purchase) of Intangibles
-1.22-0.25-0.19--
Investment in Securities
-11.6----
Other Investing Activities
--0.840.010.05-0.01
Investing Cash Flow
-99.97-28.56-2.5-0.55-0.01
Long-Term Debt Repaid
-11.64-6.84-7.45-7.64-7.35
Net Debt Issued (Repaid)
-11.64-6.84-7.45-7.64-7.35
Issuance of Common Stock
4.15450.262.02251.6-
Other Financing Activities
--1.46-1.46-
Financing Cash Flow
-7.49441.95-5.43245.4257.82
Foreign Exchange Rate Adjustments
0.42-0.160-0.02-0.1
Net Cash Flow
-246.46298.43-77.13189.7526.24
Free Cash Flow
-226.57-142.27-71.52-55.71-31.47
Free Cash Flow Margin
--15119.02%-11245.28%-2626.69%-61.14%
Free Cash Flow Per Share
-4.05-2.94-1.61-1.58-1.05
Cash Interest Paid
1.921.780.91.330.79
Cash Income Tax Paid
0.360.250.06-0.073.67
Levered Free Cash Flow
-170.31-88.67-45.36-32.43-
Unlevered Free Cash Flow
-169.12-87.55-44.8-31.6-
Change in Working Capital
-13.03-5.584.323.36-2.51
Source: S&P Global Market Intelligence. Standard template. Financial Sources.